Targeted Therapy for Advanced Non-small Cell Lung Cancers: Historical Perspective, Current Practices, and Future Development

« PreviousCurrent Problems in Cancer
Volume 33, Issue 2 , Pages 73-111, March 2009

Devalingam Mahalingam, MD, PhD
- Clinical Investigator, Institute of Drug Development, Division of Cancer Research and Therapy Center, University of Texas Health Science Center, San Antonio, Texas
Alain Mita, MD
- Assistant Professor of Medicine and Clinical Investigator, Cancer Therapy and Research Center, University of Texas Health Science Center, San Antonio, Texas
Monica M. Mita, MD
- Assistant Professor of Medicine and Clinical Investigator, Cancer Therapy and Research Center, University of Texas Health Science Center, San Antonio, Texas
Steffan T. Nawrocki, PhD
- Co-Director of Preclinical Research, The Institute for Drug Development, Cancer Therapy and Research Center, University of Texas Health Science Center, San Antonio, Texas
Francis J. Giles, MB, MD, FRCPI, FRCPath
- Deputy Director, The Cancer Therapy and Research Center, Director, The Institute for Drug Development, University of Texas Health Science Center, San Antonio, Texas